DIOSMIL
Therapeutic Area Cardiology
Principes actifs Diosmin, Hesperidin
Africa
High-quality medicines developed to meet the therapeutic needs of today and tomorrow.
For more than 30 years, PHARMA Développement has been developing, manufacturing, and marketing medications that meet the highest standards of quality, safety, and efficacy.
Supporting patients and healthcare professionals is at the heart of our commitment. Our portfolio spans several therapeutic areas, enabling us to offer solutions tailored to the needs of the French and international markets, in compliance with regulatory requirements and with a constant focus on innovation.
Since 1991, our pharmaceutical and industrial expertise has enabled us to develop reliable, accessible medications recognized for their quality, thereby helping to improve patients’ comfort and quality of life.
The list of medications varies by region and is therefore not the same from one geographic area to another. It is also subject to change over time.
METOSSOR 100 mg
Therapeutic Area Cardiology
Principes actifs Metoprolol tartrate
METOSSOR 50 mg
Therapeutic Area Cardiology
Principes actifs Metoprolol tartrate
DERMO 6 1.2 g / 100 g
Therapeutic Area Dermatology
Principes actifs Pyridoxine hydrochloride
HEMOFER, Oral Solution
Therapeutic Area Hematology
Principes actifs Ferric ammonium citrate, Folic acid, Vitamin B12
PREVERT
Therapeutic Area Hematology
Principes actifs Clopidogrel
DOLENFANT 100 mg/mL oral solution in drops
Therapeutic Area Neurology
Principes actifs Acetaminophen
DOLENFANT 125 mg / 5 ml
Therapeutic Area Neurology
Principes actifs Acetaminophen
IBUFENE
Therapeutic Area Neurology
Principes actifs Acetaminophen, Anhydrous caffeine, Ibuprofen
LEVATIR 1000 mg
Therapeutic Area Neurology
Principes actifs Levetiracetam
LEVATIR 500 mg
Therapeutic Area Neurology
Principes actifs Levetiracetam
NEUROLESS
Therapeutic Area Neurology
Principes actifs Citalopram
Report
Do you wish to make a report?
In accordance with legal and regulatory obligations governing health and safety, you can report any adverse event (medicinal or cosmetic) or suspected quality defect related to the use of one of our products.
This information is crucial for the ongoing evaluation of our safety profile. Please submit your report: directly to our monitoring department via the contact form for medications; and/or via our telephone number +33 (0)3 86 20 21 64.